🔎 Trials Near Me

Beranda › Mieloma Multipel › Washington › Tacoma

Uji klinis Mieloma Multipel di Tacoma, WA

13 studi untuk Mieloma Multipel mencari peserta di lokasi sekitar Tacoma (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

Menerima pesertaFase 3
  • Research Site, Puyallup · 8 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07391657

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Menerima pesertaFase 3
  • NorthWest Medical Specialties, PLLC, Tacoma
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07518186

Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)

Menerima pesertaFase 4
  • Northwest Medical Specialties, PLLC, Tacoma
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07609940

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

Menerima pesertaFase 3
  • NorthWest Medical Specialties, PLLC, Tacoma
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05552222

A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

Menerima pesertaFase 1
  • American Oncology Network Vista Oncology Division / Physician partner associate, Olympia · 26 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07477587

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Menerima pesertaFase 2
  • Northwest Medical Specialties, Tacoma
  • Northwest Medical Specialties, Gig Harbor · 8 mi jauhnya
  • Northwest Medical Specialties, Puyallup · 8 mi jauhnya
  • dan 1 lainnya
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT02693535

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

Menerima pesertaFase 1/2
  • Northwest Medical Specialties Tacoma /ID# 272506, Tacoma
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06953960

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

Menerima pesertaFase 1
  • Northwest Medical Specialties, Tacoma
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT05651932

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

Menerima pesertaFase 3
  • Research Site, Puyallup · 8 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT07764978

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

Menerima pesertaFase 1
  • Northwest Medical Specialties Tacoma /ID# 267117, Tacoma
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT05650632

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Menerima pesertaFase 3
  • Providence Regional Cancer System-Yelm, Yelm · 23 mi jauhnya
  • Providence Regional Cancer System-Lacey, Lacey · 23 mi jauhnya
Semua usia · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT05561387

Uji klinis Mieloma Multipel di kota lain

Studi lain di Tacoma

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.